OmniAb
our business our business model is focused on licensing our proprietary discovery technology we are meeting a global industry need poised for growth only species platform pea no partners have access to antibodies programs with product approvals in the billion total market antibodies by | OmniAb
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
4 of 22
Similar slides by OmniAb
See diffirences between slides (animation)
Investor Conference
November 2022
our business model is focused on licensing our proprietary discovery technology we are meeting a global industry need poised for growth | OmniAb
Investor Conference
November 2022
our business model is focused on licensing our proprietary discovery technology we are meeting a global industry need poised for growth | OmniAb
Related slides by other companies
Pershing Square
Activist
April 2014
industry leading new product launch program | Pershing Square
Fastly
Investor Day
June 2023
platform and product portfolio | Fastly
AbCellera
Results
February 2022
covid antibody program | AbCellera
Immatics
Investor Presentation
November 2023
potency of our proprietary format | Immatics
Other recent decks by OmniAb
See all presentations (9 decks)
Results
March 2024
Investor Presentation
August 2023
Results
August 2023
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io